Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers ICONIC
Study Type: Treatment
Phase: II
NCTID: NCT03866382
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
Phase II Trial of Tremelimumab in Patients with Metastatic Urothelial Cancer Previously Treated with PD-1/PD-L1 Blockade
Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
Study Type: Supportive Care
Phase: N/A
NCTID: NCT01503086
Principal Investigator:
Keith August
A Phase III Study of Selumetinib NSC 748727, IND 77782 or Selumetinib in Combination with Vinblastine for non-NF1, non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas LGGs Lacking BRAFV600E or IDH1 Mutations
Study Type: Treatment
Phase: III
NCTID: NCT04576117
Principal Investigator:
Keith August
A Safety Run-In And Phase II Study Evaluating The Efficacy, Safety, And Impact On The Tumor Microenvironment Of The Combination Of Tocilizumab, Atezolizumab, And Fractionated Stereotactic Radiotherapy In Recurrent Glioblastoma
Study Type: Treatment
Phase: II
NCTID: NCT04729959
Principal Investigator:
Tolga Tuncer
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG
Study Type: Treatment
Phase: II
NCTID: NCT02684058
Principal Investigator:
Kevin Ginn
Multi-Center Randomized Controlled Phase 2b Clinical Trial To Evaluate The Safety And Efficacy Of Tvi-Brain-1 Combined With Conformal Radiotherapy And Temozolomide Compared To Standard Therapy As A Treatment For Newly Diagnosed O6 -Methylguanine Methyltransferase Negative MGMT Unmethylated Grade 4 Astrocytoma Glioblastoma Multiforme; GBM
Study Type: Treatment
Phase: II
NCTID: NCT05685004
Principal Investigator:
Tolga Tuncer
A Phase 3 Randomized Study of Selumetinib versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 NF1 Associated Low-Grade Glioma LGG
Study Type: Treatment
Phase: III
NCTID: NCT03871257
Principal Investigator:
Keith August
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine DFMO
Study Type: Prevention
Phase: II
NCTID: NCT02679144
Principal Investigator:
Kevin Ginn